Rationale, design, and governance of Prospective Randomized Evaluation of Celecoxib Integrated Safety versus Ibuprofen Or Naproxen (PRECISION), a cardiovascular end point trial of nonsteroidal antiinflammatory agents in patients with arthritis-Reference-Cited by-同舟云学术

Rationale, design, and governance of Prospective Randomized Evaluation of Celecoxib Integrated Safety versus Ibuprofen Or Naproxen (PRECISION), a cardiovascular end point trial of nonsteroidal antiinflammatory agents in patients with arthritis

Published:2009-04 Issue:4 Volume:157 Page:606-612
ISSN:0002-8703
Container-title:American Heart Journal
language:en
Short-container-title:American Heart Journal

Author:

Becker Matthew C.,Wang Thomas H.,Wisniewski Lisa,Wolski Kathy,Libby Peter,Lüscher Thomas F.,Borer Jeffrey S.,Mascette Alice M.,Husni M. Elaine,Solomon Daniel H.,Graham David Y.,Yeomans Neville D.,Krum Henry,Ruschitzka Frank,Lincoff A. Michael,Nissen Steven E.

Publisher

Elsevier BV

Subject

Cardiology and Cardiovascular Medicine

Reference31 articles.

1. Celecoxib for the prevention of colorectal adenomatous polyps;Arber;N Engl J Med,2006

2. Celecoxib for the prevention of sporadic colorectal adenomas;Bertagnolli;N Engl J Med,2006

3. Cardiovascular events associated with rofecoxib in a colorectal adenoma chemoprevention trial;Bresalier;N Engl J Med,2005

4. Comparison of lumiracoxib with naproxen and ibuprofen in the Therapeutic Arthritis Research and Gastrointestinal Event Trial (TARGET), reduction in ulcer complications: randomised controlled trial;Schnitzer;Lancet,2004

5. Anti-inflammatory and upper gastrointestinal effects of celecoxib in rheumatoid arthritis: a randomized controlled trial;Simon;Jama,1999

Cited by 110 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Comparative analysis of the use of symptomatic slow acting drugs for osteoarthritis containing chondroitin sulfate or affecting its biosynthesis in patients with non-specific low back pain;Zhurnal nevrologii i psikhiatrii im. S.S. Korsakova;2023

2. Clinical events classification (CEC) in clinical trials: Report on the current landscape and future directions — proceedings from the CEC Summit 2018;American Heart Journal;2022-04

3. Cardiorenal risk of celecoxib compared with naproxen or ibuprofen in arthritis patients: insights from the PRECISION trial;European Heart Journal - Cardiovascular Pharmacotherapy;2022-03-02

4. Linking heart function and analgesia;The Neurobiology, Physiology, and Psychology of Pain;2022

5. Cardiovascular Safety of Denosumab Across Multiple Indications;Journal of Bone and Mineral Research;2020-10-23